Sébastien Fortin

10PUBLICATIONS
12CO-AUTHORS
Molecular targetsBiologically active moleculesNanomaterialsChemotherapyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 28, 2026
FOXA1 and RAB25 as Biomarkers of Breast Cancer Cell Response to CYP1A1-Activated Prodrugs: Insights from CEU-938.

Quentin Bruxelles, Geneviève Hamel-Côté, Marie-Pier Scott-Boyer

|Jul 30, 2025
Design, synthesis and biological evaluation of N-pyridinyl ureidobenzenesulfonates and their hydrochloride salts as novel water-soluble dihydroorotate dehydrogenase inhibitors inducing differentiation of acute myeloid leukemia cells.

Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez

|Apr 21, 2025
Glycerol-Based Polymer to Improve the Cellular Uptake of Liposomes.

Sabrina Roussel, Lucia Carrera Fragoso, Philippe Grenier

|Feb 26, 2025
Toxicity, Half-Life and Antitumor Activity of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as Novel Antimitotic CYP1A1-Targeted Prodrugs in Female Mouse Models.

Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Vincent Ouellette

|Sep 16, 2024
Pyridinyl 4-(2-oxoalkylimidazolidin-1-yl)benzenesulfonates and their hydrochloride salts as novel water soluble antimitotic prodrugs bioactivated by cytochrome P450 1A1 in breast cancer cells.

Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez

|Feb 13, 2023
Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver Microsomes.

Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau

Pageof 2

Frequent Collaborators

5 joint publications

Vincent Ouellette

3 joint publications

Atziri Corin Chavez Alvarez

3 joint publications

Chahrazed Bouzriba

2 joint publications

Nicolas Bertrand